MAPT and Alzheimer disease: The diagnosis of Alzheimer disease and MCI-AD was aided by magnetic resonance imaging of the brain, fluorodeoxyglucose-positron emission tomography of the brain, and cerebrospinal fluid biomarkers (beta amyloid and total tau).